


OncoTEX Email Formats
Biotechnology Research • Austin, Texas, United States • 1-10 Employees
Key Contact at OncoTEX
Jeff Heffelfinger
Executive Director - Columbus NCORP
Company overview
| Headquarters | 3800 N Lamar Blvd, Austin, Texas 78756, US |
| Phone number | +14882647 |
| Websites | |
| NAICS | 541714 |
| Employees | 1-10 |
| Socials |
About OncoTEX
OncoTEX is developing TEX Core, a world-first oncology drug platform designed to create innovative therapies capable of overcoming multiple limitations often associated with current cancer therapeutics, including the predominant platinum-based resistance. OxaliTEX is the first clinical candidate developed from the TEX Core platform for the treatment of platinum-resistant ovarian cancer. TEX Core is designed to target tumor cells by overcoming challenges associated with the current platinum-based standards-of-care (SOC).
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
OncoTEX has never raised funding before.
Frequently asked questions
4.8
40,000 users



